Approach to the pathogenesis and treatment of nonalcoholic steatohepatitis.
about
Probiotics for patients with hepatic encephalopathyProbiotics for non-alcoholic fatty liver disease and/or steatohepatitisGut microbiota and liver diseasesCost-utility analysis of nonalcoholic steatohepatitis screening.Histopathological and ultrastructural studies on the effects of electromagnetic fields on the liver of preincubated white Leghorn chicken embryo.Impact of glucose tolerance on the severity of non-alcoholic steatohepatitis.Effects of symbiotic and vitamin E supplementation on blood pressure, nitric oxide and inflammatory factors in non-alcoholic fatty liver disease.Mitochondrial DNA variants in the pathogenesis of type 2 diabetes - relevance of asian population studies.Sonographic fatty liver and hepatitis B virus carrier status: synergistic effect on liver damage in Taiwanese adultsPrognostic implication of liver histology in patients with nonalcoholic fatty liver disease in diabetesDietary whey protein lowers the risk for metabolic disease in mice fed a high-fat diet.Gut microbiota and diabetes: from pathogenesis to therapeutic perspective.N-acetylcysteine attenuates oxidative stress and liver pathology in rats with non-alcoholic steatohepatitis.Gut microbiota and inflammation.Prevalence of non-alcoholic fatty liver disease in four different weight related patient groups: association with small bowel length and risk factors.Is liver disease a threat to patients with metabolic disorders?High-sensitivity C-reactive protein and liver enzymes in individuals with Metabolic Syndrome in Talca, Chile.Non-alcoholic fatty liver disease is not related to the incidence of diabetic nephropathy in Type 2 Diabetes.Health benefits of blue-green algae: prevention of cardiovascular disease and nonalcoholic fatty liver disease.Sirt1 protects against high-fat diet-induced metabolic damage.Probiotics as a novel treatment for non-alcoholic Fatty liver disease; a systematic review on the current evidencesEffect of a Probiotic and Metformin on Liver Aminotransferases in Non-alcoholic Steatohepatitis: A Double Blind Randomized Clinical TrialMaternal high-fat diet triggers lipotoxicity in the fetal livers of nonhuman primates.Association between metabolic syndrome and the development of non-alcoholic fatty liver diseaseNonalcoholic fatty liver disease in a district general hospital: clinical presentation and risk factors.Metformin prevents hepatic steatosis by regulating the expression of adipose differentiation-related protein.Co-administration of metformin and N-acetylcysteine with dietary control improves the biochemical and histological manifestations in rats with non-alcoholic fatty liver.Animal models of non-alcoholic fatty liver disease: current perspectives and recent advances.Diet macronutrients composition in nonalcoholic Fatty liver disease: a review on the related documents.Histopathological diagnosis of non-alcoholic and alcoholic fatty liver disease.Probiotics in hepatology.The potential role of prebiotic fibre for treatment and management of non-alcoholic fatty liver disease and associated obesity and insulin resistance.Metformin in the treatment of non-alcoholic fatty liver disease: safety, efficacy and mechanism.Development of an in vitro human liver system for interrogating nonalcoholic steatohepatitis.A Fomitopsis pinicola Jeseng Formulation Has an Antiobesity Effect and Protects against Hepatic Steatosis in Mice with High-Fat Diet-Induced Obesity.Remogliflozin Etabonate Improves Fatty Liver Disease in Diet-Induced Obese Male MiceLow testosterone and non-alcoholic fatty liver disease: Evidence for their independent association in men with chronic spinal cord injury.The Korean Mistletoe (Viscum album coloratum) Extract Has an Antiobesity Effect and Protects against Hepatic Steatosis in Mice with High-Fat Diet-Induced Obesity.Probiotics and gut health: a special focus on liver diseases.Protective effects of Lactobacillus paracasei F19 in a rat model of oxidative and metabolic hepatic injury.
P2860
Q24235259-021965B6-B288-47CB-A8B7-7272CE68AA7CQ24243033-86EC7626-8982-459F-8C18-5F14D2819472Q27015127-8230D135-ED1A-4825-8544-77DDED3A20C1Q30385602-0FD2EDAF-A794-49B6-AB36-4FE54A26722BQ33519139-5F9C08F5-137C-441E-A76D-D31161576BA5Q33585588-29ECE29A-3D7A-4F04-9193-A245583A2AC1Q33667280-FAC48AD5-0A59-4908-8242-CDEA21B0AC90Q33718097-CB813CF5-457E-4579-B2FA-B595EA99F68FQ34112196-5D881E0A-C30E-4917-8E11-64D9781A95B3Q34205386-68034215-F5A8-441F-8F1B-4D7EAFC47E19Q34667482-F58E89F5-3E76-43D9-8CF9-A1050413B062Q35573510-232B710B-30D3-4AE5-B08B-F3111DC7554BQ35615839-2D00FF96-38C4-4B79-B662-95D01EBD4A4FQ35670894-FC42E816-4796-4DFE-BE2B-1B19BEAD4875Q35681834-6BB5EEBC-C837-41B3-96A0-3D893B625941Q36265230-7E66022C-533F-4A52-8A7B-B793C3F7279AQ36375377-812FA15E-EBDE-4E7F-99FC-4E60CB59307DQ36432536-AEA91860-FB31-412B-95F0-07BF9E503FE9Q36623024-3C5ED18E-2860-46DD-A919-5161FD2AD216Q36775324-75BE5C14-82D2-4BBD-B351-1C03C6C6DDCEQ37034650-361F754F-6E73-440D-892D-C47ACA411F88Q37069302-4AC62A8B-B7F1-4765-8EDB-53A9AAF743DFQ37073698-FE795DE5-76B7-4F69-905A-0F42E575A1C7Q37075582-36363017-5324-4F21-B416-642988EB476DQ37278131-E4426571-E503-41DC-8072-AAD6C733A74AQ37404646-7D4BA76B-497C-44E4-950E-3461F81CB87BQ37438847-D72BF76F-A51B-43B1-964E-CE6E6832C0A6Q37561108-BD0140D6-9A1B-4505-B440-50F29DB5FD43Q37631629-3500A489-F16C-4163-A270-0A6707F38DB7Q37858449-4748E0F7-095B-433E-88ED-329193CEB1CAQ37898517-BCCEC66F-C1FD-4B12-807B-40839FC60EF1Q37973510-56F061F8-2CBA-4955-8094-D1575AFD8DCAQ38192049-A44D0B89-B552-4E2E-87DB-3A8C3D153855Q39109576-2A14E870-0527-4FAE-A320-D1B6F3B2CCA6Q40937669-571A8FAB-6F89-456C-9615-2F1732BCC5EBQ42107886-B2CB001A-1A2E-41FC-AB6C-8AFF0DD5F4ECQ42371319-DBA3B75A-3647-4B2D-B3A9-FB690C5292D0Q42815113-99BAE0D6-E769-4075-982E-E3870B93EDC3Q42930192-706D33E5-441D-4F0A-BCE1-0BF126CE5CEAQ43006129-5906D37F-E118-4A06-9706-DC5AEAA639CC
P2860
Approach to the pathogenesis and treatment of nonalcoholic steatohepatitis.
description
2004 nî lūn-bûn
@nan
2004 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2004 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
name
Approach to the pathogenesis and treatment of nonalcoholic steatohepatitis.
@ast
Approach to the pathogenesis and treatment of nonalcoholic steatohepatitis.
@en
Approach to the pathogenesis and treatment of nonalcoholic steatohepatitis.
@nl
type
label
Approach to the pathogenesis and treatment of nonalcoholic steatohepatitis.
@ast
Approach to the pathogenesis and treatment of nonalcoholic steatohepatitis.
@en
Approach to the pathogenesis and treatment of nonalcoholic steatohepatitis.
@nl
prefLabel
Approach to the pathogenesis and treatment of nonalcoholic steatohepatitis.
@ast
Approach to the pathogenesis and treatment of nonalcoholic steatohepatitis.
@en
Approach to the pathogenesis and treatment of nonalcoholic steatohepatitis.
@nl
P2093
P1433
P1476
Approach to the pathogenesis and treatment of nonalcoholic steatohepatitis.
@en
P2093
Jesús Medina
Luisa García-Buey
Ricardo Moreno-Otero
P304
P356
10.2337/DIACARE.27.8.2057
P407
P577
2004-08-01T00:00:00Z